+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
MOREPENLAB

Morepen Laboratories Share Price

₹102.31 -5.38 (-5%)
32.11% Fall from 52W High

03 Nov, 2026 11:09 AM (IST)

Morepen Laboratories live price: ₹102.31. It opened at ₹102 vs previous close ₹108; intraday high/low: ₹102/₹102. The 50 & 200 DMA stand at ₹113.60/₹78.40.

Morepen Laboratories Performance

  • Today's Low
  • ₹102
  • Today's High
  • ₹102
  • 52 Week Low
  • ₹33
  • 52 Week High
  • ₹151
  • Open Price₹102
  • Previous Close₹108
  • Volume839,293
  • 50 DMA₹113.60
  • 100 DMA₹96.60
  • 200 DMA₹78.40

Morepen Laboratories Chart

Investment Returns

  • Over 1 Month -23.49%
  • Over 3 Month + 79.37%
  • Over 6 Month + 147.36%
  • Over 1 Year + 115.03%

Smart Investing Starts Here Start SIP with Morepen Laboratories for Steady Growth!

Invest Now

Morepen Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 29.7
  • PEG Ratio
  • 0.3
  • Market Cap Cr
  • 5,606
  • P/B Ratio
  • 4.3
  • Average True Range
  • 8
  • EPS
  • 3.4
  • Dividend Yield
  • 0.2
  • MACD Signal
  • -0.6
  • RSI
  • 39.33
  • MFI
  • 43.16

Latest Stock News Updates

Morepen Laboratories Ltd - 500288 - Announcement under Regulation 30 (LODR)-Change in Management

Change in Senior Management Personnel on account of resignation

Morepen Laboratories Ltd - 500288 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Publication financial results for the quarter and half year ended 30 September 2026 and special window for transfer and dematerialization of physical shares

Morepen Laboratories Ltd - 500288 - Announcement under Regulation 30 (LODR)-Change in Management

Change in Designation of Senior Management Personnel of the Company

Morepen Laboratories Financials

Morepen Laboratories Technicals

EMA & SMA

Current Price
₹102.31
-5.38 (-5%)
pointer
  • Bearish Moving Average 11
  • Bullish Moving Average 5
  • 20 Day
  • ₹121.60
  • 50 Day
  • ₹113.60
  • 100 Day
  • ₹96.60
  • 200 Day
  • ₹78.40

Resistance and Support

102.3 Pivot Speed
  • R3 107.70
  • R2 107.70
  • R1 107.70
  • S1 107.70
  • S2 107.70
  • S3 107.70

Morepen Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-10-27 Quarterly Results
2026-08-04 Quarterly Results
2026-05-26 Audited Results & Final Dividend (Revised)
2026-02-10 Quarterly Results
2025-11-14 Quarterly Results
Date Purpose Remarks
2026-09-19 FINAL Rs.0.20 per share(10%)Final Dividend
2025-08-30 FINAL Rs.0.20 per share(10%)Final Dividend
View Morepen Laboratories Dividend History Arrow
Date Purpose Remarks
2000-11-22 Split

Morepen Laboratories Shareholding Pattern

59.19%
35.65%
3.43%
1.71%

About Morepen Laboratories

Morepen Laboratories engaged with the medical fraternity and the wider public on matters of everyday health. Leveraging the leadership position of Saltum, the No. 1 brand in its category in the Indian pharmaceutical market, the Company conducted a dedicated campaign during Antimicrobial Resistance (AMR) Awareness Week to reinforce responsible antibiotic use among physicians and patients. View More
  • NSE Symbol
  • MOREPENLAB
  • BSE Symbol
  • 500288
  • ISIN
  • INE083A01026

Similar Stocks to Morepen Laboratories

Morepen Laboratories FAQs

Morepen Laboratories share price is ₹102 As on 03 November, 2026 | 10:55

The Market Cap of Morepen Laboratories is ₹5606.1 Cr As on 03 November, 2026 | 10:55

The P/E ratio of Morepen Laboratories is 29.7 As on 03 November, 2026 | 10:55

The PB ratio of Morepen Laboratories is 4.3 As on 03 November, 2026 | 10:55

The 52 week High & Low of Morepen Laboratories is ₹150.7/₹33 respectively As on 03 November, 2026 | 10:55

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23